Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 05 Dec 2013 for ROSETTA STONE INC, €2.5M.
Insider track record
Disclosed buys
0
Disclosed sells
10
Signal history
No signal scores available.
Laura Witt: trading record in brief
Laura Witt discloses dealings in 3 companies, chiefly Rosetta Stone Inc, Double-Take Software, Inc. and Drugmax Inc. Over a trading history stretching from 24 July 2006 to 4 December 2013, the count stands at 14 filings.
No open-market purchase appears, only 10 sales worth €135.2M. Outside the open market, there are 1 share grant. So far in 2013, the count stands at no purchases and 6 sales.
The newest entry dates from 5 December 2013: an open-market sale of €2.5M, in Rosetta Stone Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Laura Witt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
300,000 shares@ US$11.42Common StockSEC:0001179110-13-017489:0
500,000 shares@ US$11.42Common StockSEC:0001179110-13-017489:1
689,294 shares@ US$11.42Common StockSEC:0001179110-13-017489:2
6,800,508 shares0Common StockSEC:0001104659-09-025800:0
6,869,768 shares0Common StockSEC:0001181431-06-071613:0
1,882,795 shares0Common StockSEC:0001181431-06-071613:1
39,062 shares0Common StockSEC:0001207706-06-000002:0
7 of 7 declarations
